BIOMAT Database Logo BIOMAT Database Logo

[Bromocryptin in the treatment of Itsenko-Cushing's disease]. 1979

E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009347 Nelson Syndrome A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000305 Adrenal Cortex Hormones HORMONES produced by the ADRENAL CORTEX, including both steroid and peptide hormones. The major hormones produced are HYDROCORTISONE and ALDOSTERONE. Adrenal Cortex Hormone,Corticoid,Corticoids,Corticosteroid,Corticosteroids,Cortex Hormone, Adrenal,Hormone, Adrenal Cortex,Hormones, Adrenal Cortex

Related Publications

E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Itsenko-Cushing's disease].
August 1984, Fel'dsher i akusherka,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[The results of neurosurgical treatment in Itsenko-Cushing's disease].
January 1997, Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Radiation and combined treatment of Itsenko-Cushing's disease].
February 1980, Meditsinskaia radiologiia,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Radiotherapy in the treatment of children with Itsenko-Cushing's disease].
January 1989, Pediatriia,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[The functional condition of blood-brain barrier in Itsenko-Cushing's disease and diencephalic syndrome of Itsenko-Cushing's disease].
January 1968, Problemy endokrinologii,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Mental disorders in Itsenko-Cushing's disease].
January 1958, Problemy endokrinologii i gormonoterapii,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Ultrastructure of the kidney in Itsenko-Cushing's disease].
January 1970, Arkhiv patologii,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Pregnancy and labor after successful treatment of Itsenko-Cushing's disease].
August 1968, Voprosy okhrany materinstva i detstva,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Sympathetic-adrenal system in Itsenko-Cushing's disease].
January 1982, Laboratornoe delo,
E A Vasiukova, and G S Zefirova, and G V Ibragimova, and A M Mkrtumian, and M B Khaĭkina
[Blood ACTH levels in Itsenko-Cushing's disease].
January 1971, Problemy endokrinologii,
Copied contents to your clipboard!